AstraZeneca has taken full ownership of Omniose, bringing the biotech into its Infectious Disease Unit through an acquisition that Omniose announced on Tuesday, Nov. 10.
Business
Add as a preferred source on GoogleAstraZeneca Takes Full Ownership of Omniose in Biotech Acquisition
Omniose announced the acquisition Tuesday, Nov. 10; the biotech is now part of AstraZeneca’s Infectious Disease Unit.
Updated 1 min read
Related articles
Business
Predictive Technology Group Appoints Dr. Gregory A. Prince to Its Scientific Advisory Board
SALT LAKE CITY, Jan. 17, 2018 -- Dr. Gregory A. Prince will join PRED’s Scientific Advisory Board. As a co-founder and CEO of Virion Systems, Inc., Dr. Prince brings pharmaceutical research and development and commercial…
Business
Wonder Says It Filed Confidentially for IPO; Acquisitions Total at Least $1 Billion
Wonder operates about 170 U.S. locations and has raised more than $3 billion in venture funding.
Business
Labcorp Raises 2026 Revenue Outlook as Millennium Health Deal Closes
Third-quarter revenue reached $3.81 billion, while adjusted earnings per share rose 14.5% to $4.78.